prednisolone has been researched along with Hepatitis B Virus Infection in 168 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this multicentre, randomised, controlled, clinical trial was to evaluate the effect of prednisolone followed by lymphoblastoid interferon treatment in chronic hepatitis B." | 9.08 | Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial Group. ( Bassendine, M; Benhamou, JP; Berthelot, P; Bindslev, N; Enriquez, J; Krogsgaard, K; Lindberg, J; Marcellin, P; Ouzan, D; Ring-Larsen, H; Sanchez-Tapias, JM; Tran, A; Trepo, C, 1996) |
| "Forty-one hepatitis B e antigen (HBeAg) and hepatitis B virus (HBV) DNA positive Chinese patients with chronic active hepatitis B were randomized to receive either prednisolone or placebo oral for 8 weeks." | 9.07 | A randomised double-blind placebo-controlled trial of prednisolone therapy in HBeAg and HBV DNA positive Chinese patients with chronic active hepatitis B. ( Lee, SD; Lin, HC; Lo, KJ; Tong, MJ; Tsai, YT; Wu, JC, 1991) |
| "Twenty-nine patients with chronic hepatitis B, presenting both hepatitis B surface antigen and hepatitis B virus deoxyribonucleic acid in serum, were studied in a randomized trial treatment consisting of oral prednisolone for 28 days followed 14 days after steroid withdrawal, by either a 55 s." | 9.07 | Short-term prednisolone followed by recombinant human alpha-interferon alone or combined with adenine-arabinoside in chronic hepatitis B. A prospective and randomized trial. ( Blayau, M; Brissot, P; David, V; Deugnier, Y; Guéguen, M; Guyader, D; Jacquelinet, C; Jouanolle, H; Lescoat, G; Messner, M, 1991) |
| "The efficacy of adenine arabinoside (Ara-A) alone or in combination with prednisolone utilizing its withdrawal effect was studied in 43 patients with deoxyribonucleic acid polymerase- and hepatitis B e antigen-positive chronic hepatitis." | 9.05 | Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B. A controlled study. ( Hirota, K; Imazeki, F; Ito, Y; Mori, J; Okuda, K; Omata, M; Uchiumi, K; Yokosuka, O, 1985) |
| "Changes in markers of hepatitis B viral replication and standard liver function tests were studied in 30 patients with HBsAg positive chronic liver disease starting or stopping prednisolone/azathioprine therapy, and compared with those occurring in 15 patients who did not receive therapy." | 9.05 | Effects of prednisolone/azathioprine in chronic hepatitis B viral infection. ( Bassendine, MF; Craxi, A; Murray, AK; Sherlock, S; Thomas, HC; Weller, IV, 1982) |
| "To study the efficacy of corticosteroids in chronic active hepatitis (CAH) positive for hepatitis B surface antigen (HBsAg), we pair-randomized 51 patients to receive either 15 to 20 mg of prednisolone per day or a placebo." | 9.05 | Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. ( Lai, CL; Lam, KC; Trepo, C; Wu, PC, 1981) |
| "A 49-year-old-man, a healthy carrier of hepatitis B virus (HBV), received chemotherapy with a rituximab/cyclo- phosphamide/doxorubicin/vincristine/prednisolone (R-CHOP) regimen for non-Hodgkin's lymphoma." | 7.75 | [A case of drug-induced liver injury caused by entecavir for treatment of hepatitis B virus reactivation during RCHOP in a patient with non-Hodgkin lymphoma]. ( Kitada, N; Kobayashi, M; Kondo, M; Mori, A; Morita, S; Okamoto, T; Tsuji, T; Watari, M; Yoshioka, M, 2009) |
| "Here we report three cases of hepatitis B virus (HBV) reactivation after cessation of preemptive lamivudine therapy in B-cell lymphoma patients treated with rituximab plus CHOP (R-CHOP)." | 7.75 | [Hepatitis B virus reactivation after cessation of prophylactic lamivudine therapy in B-cell lymphoma patients treated with rituximab combined CHOP therapy]. ( Fukai, K; Ise, M; Kojima, H; Kumagai, K; Mimura, N; Sakai, C; Takagi, T; Tsujimura, H; Yokosuka, O, 2009) |
| "Twenty patients with hepatitis B e antigen (HBeAg) -positive chronic hepatitis, who received 40 mg of prednisolone per day for three weeks followed by withdrawal, were studied for changes in alanine aminotransferase (ALT), triiodothyronine (T3), thyroxine (T4), and hepatitis B virus DNA polymerase (HBV-DNAp) levels determined before and during prednisolone treatment and after its withdrawal." | 7.68 | Triiodothyronine level and triiodothyronine/thyroxine ratio in HBeAg-positive chronic hepatitis patients treated with prednisolone withdrawal. ( Itoh, S; Marutani, K; Matsuo, S; Oda, T; Sasaki, K, 1990) |
| "In 1981, we initiated combination therapy of short-term prednisolone withdrawal and adenine arabinoside (ARA-A) or interferon (IF) for the treatment of chronic hepatitis B." | 7.67 | Combination of prednisolone withdrawal and antiviral agents (adenine arabinoside, interferon) in chronic hepatitis B. A long-term follow-up study. ( Omata, M; Uchiumi, K, 1986) |
| "Short-term prednisolone therapy was instituted on 27 patients with chronic active hepatitis (CAH) type B, in an attempt to induce seroconversion from hepatitis B e antigen (HBeAg) to the corresponding antibody (anti-HBe)." | 7.67 | Short-term prednisolone for inducing seroconversion from hepatitis B e antigen to antibody along with clinical improvement in patients with chronic active hepatitis type B. ( Ikeda, K; Kojima, M; Kumada, H; Mayumi, M; Seto, S; Suzuki, H; Tsukada, T; Yoshida, A, 1987) |
| "Prednisolone was discovered to have an adverse effect on seropositive CAH, to activate virus replication in liver tissue, intensify necrotic alterations in the parenchyma and inflammatory reaction in the portal tracts." | 6.66 | [Evaluation of therapeutic effectiveness of prednisolone in patients with chronic active hepatitis based on the morphometry of liver biopsy specimens]. ( Mansurov, KhKh; Mirodzhov, GK; Mishanina, ZG; Pavlov, VL, 1985) |
| "Polyarteritis nodosa was confirmed by biopsy." | 5.31 | Successful treatment of hepatitis B virus associated polyarteritis nodosa with a combination of prednisolone, alpha-interferon and lamivudine. ( Erhardt, A; Guillevin, L; Häussinger, D; Neuen-Jacob, E; Sagir, A, 2000) |
| "For hepatitis B virus associated polyarteritis nodosa, alpha interferon and plasma exchanges have been proposed to be the first-line treatment." | 5.31 | Hepatitis B associated fulminant polyarteritis nodosa: successful treatment with pulse cyclophosphamide, prednisolone and lamivudine following emergency surgery. ( Chan, WM; Fung, TT; Hui, PK; Lam, KM; Lau, CF; Loo, CK; Tung, YM; Yip, WC, 2002) |
| "Treatment with prednisolone alone did not prevent progression to overt hepatic failure." | 5.30 | Recovery from life-threatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy. ( Chamuleau, RA; de Man, RA; Jones, EA; Rietbroek, RC; Smorenburg, S; ter Borg, F, 1998) |
| "The aim of this multicentre, randomised, controlled, clinical trial was to evaluate the effect of prednisolone followed by lymphoblastoid interferon treatment in chronic hepatitis B." | 5.08 | Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial Group. ( Bassendine, M; Benhamou, JP; Berthelot, P; Bindslev, N; Enriquez, J; Krogsgaard, K; Lindberg, J; Marcellin, P; Ouzan, D; Ring-Larsen, H; Sanchez-Tapias, JM; Tran, A; Trepo, C, 1996) |
| "To evaluate the effect of interferon and the benefit of prednisolone pretreatment in Oriental patients with chronic active hepatitis B, 120 male Chinese patients were randomly allocated to receive: 1) group A: a 4-week course of prednisolone followed by 2 weeks of no treatment and then a 12-week course of human lymphoblastoid interferon, 4 to 6 MU/m2 intramuscularly; 2) group B: as group A, but with placebo given instead of prednisolone; 3) group C: an 18-week course of placebo." | 5.07 | Beneficial effect of prednisolone withdrawal followed by human lymphoblastoid interferon on the treatment of chronic type B hepatitis in Asians: a randomized controlled trial. ( Chen, TJ; Chien, RN; Chu, CM; Liaw, YF; Lin, SM; Sheen, IS, 1994) |
| "Forty-one hepatitis B e antigen (HBeAg) and hepatitis B virus (HBV) DNA positive Chinese patients with chronic active hepatitis B were randomized to receive either prednisolone or placebo oral for 8 weeks." | 5.07 | A randomised double-blind placebo-controlled trial of prednisolone therapy in HBeAg and HBV DNA positive Chinese patients with chronic active hepatitis B. ( Lee, SD; Lin, HC; Lo, KJ; Tong, MJ; Tsai, YT; Wu, JC, 1991) |
| "Twenty-nine patients with chronic hepatitis B, presenting both hepatitis B surface antigen and hepatitis B virus deoxyribonucleic acid in serum, were studied in a randomized trial treatment consisting of oral prednisolone for 28 days followed 14 days after steroid withdrawal, by either a 55 s." | 5.07 | Short-term prednisolone followed by recombinant human alpha-interferon alone or combined with adenine-arabinoside in chronic hepatitis B. A prospective and randomized trial. ( Blayau, M; Brissot, P; David, V; Deugnier, Y; Guéguen, M; Guyader, D; Jacquelinet, C; Jouanolle, H; Lescoat, G; Messner, M, 1991) |
| "The efficacy of human lymphoblastoid interferon (Wellferon) therapy was measured in 20 children with chronic hepatitis B with or without pretreatment with prednisolone." | 5.06 | Treatment of children with chronic hepatitis B with a combination of steroids and human lymphoblastoid interferon. ( Barigione, G; Cirillo, C; Facco, F; Giacchino, R; Giambartolomei, G; Navone, C; Terragna, A; Timitilli, A, 1988) |
| "To study the efficacy of corticosteroids in chronic active hepatitis (CAH) positive for hepatitis B surface antigen (HBsAg), we pair-randomized 51 patients to receive either 15 to 20 mg of prednisolone per day or a placebo." | 5.05 | Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. ( Lai, CL; Lam, KC; Trepo, C; Wu, PC, 1981) |
| "Changes in markers of hepatitis B viral replication and standard liver function tests were studied in 30 patients with HBsAg positive chronic liver disease starting or stopping prednisolone/azathioprine therapy, and compared with those occurring in 15 patients who did not receive therapy." | 5.05 | Effects of prednisolone/azathioprine in chronic hepatitis B viral infection. ( Bassendine, MF; Craxi, A; Murray, AK; Sherlock, S; Thomas, HC; Weller, IV, 1982) |
| "The efficacy of adenine arabinoside (Ara-A) alone or in combination with prednisolone utilizing its withdrawal effect was studied in 43 patients with deoxyribonucleic acid polymerase- and hepatitis B e antigen-positive chronic hepatitis." | 5.05 | Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B. A controlled study. ( Hirota, K; Imazeki, F; Ito, Y; Mori, J; Okuda, K; Omata, M; Uchiumi, K; Yokosuka, O, 1985) |
| "Immunosuppressive treatment with prednisolone and/or azathioprine has been assessed in three chronic liver diseases with immunological features, namely chronic active hepatitis, cryptogenic cirrhosis and primary biliary cirrhosis." | 5.04 | Immunosuppressive therapy in chronic liver disease. ( Sherlock, S, 1978) |
| "The patient was administered with entecavir and glycyrrhizic acid agent, and then the disease was resolved successfully with hepatitis B surface antigen serological conversion." | 3.85 | Hepatitis B virus infection in an HBsAb-positive lymphoma patient who received chemotherapy: A case report. ( Kang, FB; Sun, DX; Wang, L, 2017) |
| " Genotype has been compared with treatment response in children infected perinatally with hepatitis B following treatment with oral antiviral drugs (lamivudine or adefovir) or interferon (IFN) alone and with prednisolone priming (Pred/IFN)." | 3.78 | Does genotype predict response to treatment in children infected with hepatitis B perinatally? ( Boxall, E; Kaskar, S; Kelly, D; Sira, J; Workman, J, 2012) |
| "Here we report three cases of hepatitis B virus (HBV) reactivation after cessation of preemptive lamivudine therapy in B-cell lymphoma patients treated with rituximab plus CHOP (R-CHOP)." | 3.75 | [Hepatitis B virus reactivation after cessation of prophylactic lamivudine therapy in B-cell lymphoma patients treated with rituximab combined CHOP therapy]. ( Fukai, K; Ise, M; Kojima, H; Kumagai, K; Mimura, N; Sakai, C; Takagi, T; Tsujimura, H; Yokosuka, O, 2009) |
| "A 49-year-old-man, a healthy carrier of hepatitis B virus (HBV), received chemotherapy with a rituximab/cyclo- phosphamide/doxorubicin/vincristine/prednisolone (R-CHOP) regimen for non-Hodgkin's lymphoma." | 3.75 | [A case of drug-induced liver injury caused by entecavir for treatment of hepatitis B virus reactivation during RCHOP in a patient with non-Hodgkin lymphoma]. ( Kitada, N; Kobayashi, M; Kondo, M; Mori, A; Morita, S; Okamoto, T; Tsuji, T; Watari, M; Yoshioka, M, 2009) |
| "Our results provide pharmacoeconomic support for the use of lamivudine prophylaxis in patients undergoing chemotherapy for lymphoma treatment." | 3.74 | Hepatitis B prophylaxis in patients undergoing chemotherapy for lymphoma: a decision analysis model. ( Dong, MH; Joseph, TA; Saab, S; Tong, MJ, 2007) |
| " Immunosuppressive treatment with initially 60mg/d prednisolone improved the skin condition but activated the chronic hepatitis, GPT rising up to 240 U/l." | 3.69 | [Hepatitis-B-associated vasculitis. Clinical course with glucocorticoid and alpha-interferon therapy]. ( Glück, T; Weber, P; Wiedmann, KH, 1994) |
| "Twenty patients with hepatitis B e antigen (HBeAg) -positive chronic hepatitis, who received 40 mg of prednisolone per day for three weeks followed by withdrawal, were studied for changes in alanine aminotransferase (ALT), triiodothyronine (T3), thyroxine (T4), and hepatitis B virus DNA polymerase (HBV-DNAp) levels determined before and during prednisolone treatment and after its withdrawal." | 3.68 | Triiodothyronine level and triiodothyronine/thyroxine ratio in HBeAg-positive chronic hepatitis patients treated with prednisolone withdrawal. ( Itoh, S; Marutani, K; Matsuo, S; Oda, T; Sasaki, K, 1990) |
| "To determine the effect of immunosuppressive therapy on hepatic expression of hepatitis B virus (HBV) DNA and antigens in vivo, serial biopsies from 12 patients with chronic active hepatitis B who had been given immunosuppressive therapy (prednisolone 10-15 mg +/- azathioprine 75-125 mg daily) in an earlier period were studied using immunohistochemistry and non-isotopic in situ hybridization." | 3.68 | Effects of immunosuppressive therapy on hepatic expression of hepatitis B viral genome and gene products. ( Alexander, GJ; Bird, GL; Lau, JY; Williams, R, 1993) |
| "In 1981, we initiated combination therapy of short-term prednisolone withdrawal and adenine arabinoside (ARA-A) or interferon (IF) for the treatment of chronic hepatitis B." | 3.67 | Combination of prednisolone withdrawal and antiviral agents (adenine arabinoside, interferon) in chronic hepatitis B. A long-term follow-up study. ( Omata, M; Uchiumi, K, 1986) |
| " In the cyclic self-limiting forms of hepatitis B, the children developed immunologic unbalance with progressive hypercortisolemia, being an adequate reaction of the stressor systems and not requiring prednisolone administration." | 3.67 | [Cortisol level and immunosuppression in viral hepatitis B in children and the approach to its treatment with glucocorticoids]. ( Balikin, VF; Panova, LA; Sukharev, VM, 1989) |
| "Two patients with nephrotic syndrome developed fatal fulminant hepatitis B following withdrawal of prednisolone or cyclophosphamide." | 3.67 | Fulminant hepatic failure in nephrotic syndrome related to withdrawal of immunosuppressive therapy. ( Onwubalili, JK, 1988) |
| "Changes in the host interferon system during short-term steroid hormone (prednisolone) withdrawal therapy in seven patients with HBeAg-positive chronic hepatitis B were investigated by estimating the in vitro interferon-alpha production in peripheral blood lymphocytes and 2-5 oligoadenylate synthetase activity in the serum." | 3.67 | Activities of the interferon system in patients with HBsAg-positive chronic hepatitis B during short-term steroid withdrawal therapy. ( Hashimoto, T; Hattori, N; Hinoue, Y; Hirai, N; Kobayashi, K; Morioka, T; Shimizu, M; Tanaka, N, 1988) |
| "Short-term prednisolone therapy was instituted on 27 patients with chronic active hepatitis (CAH) type B, in an attempt to induce seroconversion from hepatitis B e antigen (HBeAg) to the corresponding antibody (anti-HBe)." | 3.67 | Short-term prednisolone for inducing seroconversion from hepatitis B e antigen to antibody along with clinical improvement in patients with chronic active hepatitis type B. ( Ikeda, K; Kojima, M; Kumada, H; Mayumi, M; Seto, S; Suzuki, H; Tsukada, T; Yoshida, A, 1987) |
| "Renal insufficiency was determined in 30%." | 2.72 | Hepatitis-B virus-associated nephropathies in adults: a clinical study in Thailand. ( Eiam-Ong, S; Kanjanabuch, T; Lewsuwan, S; Panomsak, S, 2006) |
| "Sixty patients with chronic active hepatitis B and positive serum HBV-DNA were randomized into two treatment groups (n = 20, respectively) and one control group (no treatment; n = 20)." | 2.67 | Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B. ( Heintges, T; Niederau, C; Niederau, M; Stremmel, W; Strohmeyer, G, 1992) |
| "Fifty-six patients with chronic active hepatitis (CAH) received immunosuppressive treatment (corticosteroids combined with azathioprine)." | 2.66 | HBeAg/anti-HBe seroconversion during and after protracted immunosuppressive treatment in type B chronic hepatitis. ( Bessone, F; Fay, OH; Palazzi, J; Rojman, JA; Tanno, H, 1988) |
| "Prednisolone was discovered to have an adverse effect on seropositive CAH, to activate virus replication in liver tissue, intensify necrotic alterations in the parenchyma and inflammatory reaction in the portal tracts." | 2.66 | [Evaluation of therapeutic effectiveness of prednisolone in patients with chronic active hepatitis based on the morphometry of liver biopsy specimens]. ( Mansurov, KhKh; Mirodzhov, GK; Mishanina, ZG; Pavlov, VL, 1985) |
| "Prednisolone withdrawal was combined with interferon in 5 patients." | 2.66 | Recombinant leukocyte a interferon treatment in patients with chronic hepatitis B virus infection. Pharmacokinetics, tolerance, and biologic effects. ( Imazeki, F; Ito, Y; Mori, J; Okuda, K; Omata, M; Uchiumi, K; Yokosuka, O, 1985) |
| "Thirty-six patients with biopsy-proved chronic active hepatitis (CAH) were randomized." | 2.65 | Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study). ( Jávor, T; Kádas, I; Kerekes, E; Paál, M; Pár, A, 1983) |
| "Dermatomyositis is an idiopathic inflammatory myopathy with specific cutaneous manifestations, which is closely associated with malignancy." | 2.58 | Dermatomyositis as an extrahepatic manifestation of hepatitis B virus-related hepatocellular carcinoma: A case report and literature review. ( Han, J; Kwong, TNY; Liu, J; Wang, S, 2018) |
| "Other indications include primary biliary cirrhosis and fulminant hepatitis but only in limited situations." | 2.39 | [Synthetic glucocorticoid therapy in liver diseases]. ( Hino, K; Iino, S; Yasuda, K, 1994) |
| "Since prednisolone is used to treat rheumatoid arthritis at a dose ≤10 mg/d, the patients were divided based on the prednisolone dose into the groups treated at >10 and ≤10 mg/d, and the onset time was investigated in each group." | 1.46 | Factorial Analysis of Hepatitis B Virus Reactivation-Induced Hepatitis B Using JADER. ( Hara, A; Kizu, J; Matsumoto, K; Yokoyama, Y, 2017) |
| "After LT, an immunosuppressive regimen without steroids could be a safe and feasible treatment for HBVrelated HCC patients, thus resulting in the reduction of HBV recurrence." | 1.43 | Efficacy and Safety of a Steroid-Free Immunosuppressive Regimen after Liver Transplantation for Hepatocellular Carcinoma. ( Shen, Y; Wang, C; Wang, W; Wei, Q; Wu, J; Xie, H; Xu, X; Zhang, M; Zheng, S; Zhou, L; Zhuang, L; Zhuang, R, 2016) |
| "The coexistence of hepatocellular carcinoma (HCC) and non-Hodgkin's lymphoma (NHL) in the liver is rare." | 1.42 | Coexistence of hepatoma with mantle cell lymphoma in a hepatitis B carrier. ( Cheng, HT; Chuang, WY; Huang, HC; Kao, HW; Lee, MH; Lin, YC, 2015) |
| "A 62-year-old woman with decompensated liver cirrhosis secondary to hepatitis B (Child-Pugh C, MELD score 11 points) and chronic renal failure due to diabetic nephropathy (Cr 1." | 1.40 | [Case report of introducing MMF and steroids as an immunosuppressive therapy after living-donor liver transplantation for a patient with the diabetic nephropathy]. ( Furuta, T; Harimoto, N; Iguchi, T; Ikeda, T; Ikegami, T; Kawanaka, H; Kuramitsu, S; Maehara, Y; Ninomiya, M; Shirabe, K; Soejima, Y; Tamada, R; Uchiyama, H; Yamashita, Y; Yoshizumi, T, 2014) |
| "Epidermodysplasia verruciformis has also been reported in immunosuppressed patients, most notably those with HIV infection." | 1.38 | Epidermodysplasia verruciformis associated with plasmablastic lymphoma and hepatitis B virus infection. ( Azadmanesh, K; Babaheidarian, P; Mirzaie, AZ; Mohammadpour, M; Parvaneh, N; Rahmani, H; Shayanfar, N; Sohrabi, A, 2012) |
| "Warm antibody autoimmune haemolytic anaemia, a rare disease (0." | 1.37 | Warm autoimmune haemolytic anaemia and autoimmune hepatitis in an asymptomatic carrier of hepatitis B virus. ( Abdul Muqtadir, K; Khawaja, S; Taj, Y, 2011) |
| "Patients with asthma or COPD (n = 198), who were hepatitis B surface antigen-seropositive and had been treated with ICS, were identified retrospectively." | 1.36 | Risk of hepatitis B virus reactivation in patients with asthma or chronic obstructive pulmonary disease treated with corticosteroids. ( Chang, YS; Cho, SH; Kim, KM; Kim, MN; Kim, SH; Kim, TW; Kim, W; Kim, YY; Kwon, JW; Min, KU; Park, HW, 2010) |
| "For hepatitis B virus associated polyarteritis nodosa, alpha interferon and plasma exchanges have been proposed to be the first-line treatment." | 1.31 | Hepatitis B associated fulminant polyarteritis nodosa: successful treatment with pulse cyclophosphamide, prednisolone and lamivudine following emergency surgery. ( Chan, WM; Fung, TT; Hui, PK; Lam, KM; Lau, CF; Loo, CK; Tung, YM; Yip, WC, 2002) |
| "Polyarteritis nodosa was confirmed by biopsy." | 1.31 | Successful treatment of hepatitis B virus associated polyarteritis nodosa with a combination of prednisolone, alpha-interferon and lamivudine. ( Erhardt, A; Guillevin, L; Häussinger, D; Neuen-Jacob, E; Sagir, A, 2000) |
| "Treatment with prednisolone alone did not prevent progression to overt hepatic failure." | 1.30 | Recovery from life-threatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy. ( Chamuleau, RA; de Man, RA; Jones, EA; Rietbroek, RC; Smorenburg, S; ter Borg, F, 1998) |
| "Liver biopsy showed severe chronic active hepatitis with confluent necrosis or acinar hepatitis in all." | 1.28 | Effect of short-term prednisolone therapy in patients with severe chronic type B hepatitis. ( Chung, WK; Kim, HY; Park, CK; Shim, KS; Yoo, JY, 1989) |
| "The effectiveness of antiviral treatment on chronic hepatitis B, especially the priority of interferon with steroid withdrawal, was thought to be established through this study." | 1.28 | Effects of antiviral agents on chronic hepatitis B. Analysis using Cox proportional hazard model. ( Imazeki, F; Ohto, M; Omata, M; Takano, S; Yokosuka, O, 1992) |
| " In order to better understand the effects and mechanism of action of these treatments, we treated ducks chronically infected with duck hepatitis B virus (DHBV) with different dosage regimens of the two therapies." | 1.27 | Effects of adenine arabinoside and corticosteroid on replication of duck hepatitis B virus DNA in the liver. ( Hirota, K; Okuda, K; Omata, M; Sherker, AH; Yokosuka, O, 1986) |
| "Chronic persistent hepatitis is a benign condition and special treatment is not necessary." | 1.26 | Treatment of chronic hepatitis. ( Sherlock, S, 1980) |
| "Later, primary hepatocellular carcinoma assumes increasing importance." | 1.25 | Viral hepatitis and cirrhosis. ( Sherlock, S, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 84 (50.00) | 18.7374 |
| 1990's | 48 (28.57) | 18.2507 |
| 2000's | 17 (10.12) | 29.6817 |
| 2010's | 19 (11.31) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Odolini, S | 1 |
| Lanza, P | 1 |
| Angiola, A | 1 |
| Zaltron, S | 1 |
| Urbinati, L | 1 |
| Vavassori, A | 1 |
| Nasta, P | 1 |
| Festa, E | 1 |
| Gargiulo, F | 1 |
| Rodella, A | 1 |
| Caruso, A | 1 |
| Casari, S | 1 |
| Castelli, F | 1 |
| Viganò, M | 1 |
| Hara, A | 1 |
| Matsumoto, K | 1 |
| Yokoyama, Y | 1 |
| Kizu, J | 1 |
| Tavakolpour, S | 1 |
| Soori, T | 1 |
| Noormohammadpour, P | 1 |
| Balighi, K | 1 |
| Mahmoudi, H | 1 |
| Daneshpazhooh, M | 1 |
| Kang, FB | 1 |
| Wang, L | 1 |
| Sun, DX | 1 |
| Fujiwara, K | 1 |
| Yasui, S | 1 |
| Haga, Y | 1 |
| Nakamura, M | 1 |
| Yonemitsu, Y | 1 |
| Arai, M | 1 |
| Kanda, T | 1 |
| Oda, S | 1 |
| Yokosuka, O | 6 |
| Kato, N | 1 |
| Han, J | 1 |
| Wang, S | 1 |
| Kwong, TNY | 1 |
| Liu, J | 1 |
| Takagi, H | 1 |
| Hoshino, T | 1 |
| Naganuma, A | 1 |
| Koitabashi, E | 1 |
| Uehara, S | 1 |
| Sakamoto, N | 1 |
| Kudo, T | 1 |
| Ryusaki, K | 1 |
| Kakizaki, S | 1 |
| Okamoto, H | 1 |
| Yoshida, K | 1 |
| Kuramitsu, S | 1 |
| Iguchi, T | 1 |
| Ninomiya, M | 1 |
| Yamashita, Y | 1 |
| Harimoto, N | 1 |
| Ikegami, T | 1 |
| Uchiyama, H | 1 |
| Yoshizumi, T | 1 |
| Soejima, Y | 1 |
| Shirabe, K | 1 |
| Kawanaka, H | 1 |
| Ikeda, T | 1 |
| Furuta, T | 1 |
| Tamada, R | 1 |
| Maehara, Y | 1 |
| Lee, MH | 1 |
| Lin, YC | 1 |
| Cheng, HT | 1 |
| Chuang, WY | 1 |
| Huang, HC | 1 |
| Kao, HW | 1 |
| Wei, Q | 1 |
| Xu, X | 1 |
| Wang, C | 1 |
| Zhuang, R | 1 |
| Zhuang, L | 1 |
| Zhou, L | 1 |
| Xie, H | 1 |
| Wu, J | 1 |
| Zhang, M | 1 |
| Shen, Y | 1 |
| Wang, W | 1 |
| Zheng, S | 1 |
| Lim, SM | 1 |
| Jang, JW | 1 |
| Kim, BW | 1 |
| Choi, H | 1 |
| Choi, KY | 1 |
| Park, SJ | 1 |
| Han, CW | 1 |
| Koo, YX | 1 |
| Tan, DS | 1 |
| Tan, BH | 1 |
| Quek, R | 1 |
| Tao, M | 1 |
| Lim, ST | 1 |
| Kondo, M | 1 |
| Kitada, N | 1 |
| Kobayashi, M | 1 |
| Morita, S | 1 |
| Yoshioka, M | 1 |
| Tsuji, T | 1 |
| Mori, A | 1 |
| Okamoto, T | 1 |
| Watari, M | 1 |
| Mimura, N | 1 |
| Tsujimura, H | 1 |
| Ise, M | 1 |
| Sakai, C | 1 |
| Kojima, H | 1 |
| Fukai, K | 1 |
| Takagi, T | 1 |
| Kumagai, K | 1 |
| Montineri, A | 1 |
| Nigro, L | 1 |
| Chiarenza, A | 1 |
| Larocca, L | 1 |
| La Rosa, R | 1 |
| Iacobello, C | 1 |
| Di Raimondo, F | 1 |
| Fatuzzo, F | 1 |
| Leung, VK | 2 |
| Lee, CK | 1 |
| Chau, TN | 2 |
| Cheung, WI | 2 |
| Lo, FH | 2 |
| Lai, KB | 1 |
| Lin, CK | 1 |
| Kim, TW | 1 |
| Kim, MN | 1 |
| Kwon, JW | 1 |
| Kim, KM | 1 |
| Kim, SH | 1 |
| Kim, W | 1 |
| Park, HW | 1 |
| Chang, YS | 1 |
| Cho, SH | 1 |
| Min, KU | 1 |
| Kim, YY | 1 |
| Numata, A | 1 |
| Akimoto, T | 1 |
| Toshima, M | 1 |
| Iwazu, Y | 1 |
| Otani, N | 1 |
| Miki, T | 1 |
| Sugase, T | 1 |
| Saito, O | 1 |
| Hamano, Y | 1 |
| Takemoto, F | 1 |
| Ueda, Y | 1 |
| Muto, S | 1 |
| Kusano, E | 1 |
| Lin, SY | 1 |
| Fung, KS | 1 |
| Lam, YK | 1 |
| Khawaja, S | 1 |
| Abdul Muqtadir, K | 1 |
| Taj, Y | 1 |
| Boxall, E | 1 |
| Sira, J | 1 |
| Kaskar, S | 1 |
| Workman, J | 1 |
| Kelly, D | 1 |
| Shayanfar, N | 1 |
| Babaheidarian, P | 1 |
| Rahmani, H | 1 |
| Azadmanesh, K | 1 |
| Sohrabi, A | 1 |
| Mohammadpour, M | 1 |
| Mirzaie, AZ | 1 |
| Parvaneh, N | 1 |
| Cheng, AL | 1 |
| Hsiung, CA | 1 |
| Su, IJ | 2 |
| Chen, PJ | 1 |
| Chang, MC | 1 |
| Tsao, CJ | 1 |
| Kao, WY | 1 |
| Uen, WC | 1 |
| Hsu, CH | 1 |
| Tien, HF | 1 |
| Chao, TY | 1 |
| Chen, LT | 1 |
| Whang-Peng, J | 1 |
| BENNETT, JR | 1 |
| HOFF, WV | 1 |
| Ohshiro, Y | 1 |
| Tawata, M | 1 |
| Takasu, N | 1 |
| Gambichler, T | 1 |
| Paech, V | 1 |
| Rotterdam, S | 1 |
| Stücker, M | 1 |
| Boms, S | 1 |
| Altmeyer, P | 1 |
| Zanati, SA | 1 |
| Locarnini, SA | 1 |
| Dowling, JP | 1 |
| Angus, PW | 1 |
| Dudley, FJ | 1 |
| Roberts, SK | 1 |
| Tamaki, T | 1 |
| Panomsak, S | 1 |
| Lewsuwan, S | 1 |
| Eiam-Ong, S | 1 |
| Kanjanabuch, T | 1 |
| Saab, S | 1 |
| Dong, MH | 1 |
| Joseph, TA | 1 |
| Tong, MJ | 2 |
| Kohlhaas, K | 1 |
| Brechmann, T | 1 |
| Vorgerd, M | 1 |
| Zizer, E | 1 |
| Hasel, C | 1 |
| Seufferlein, T | 1 |
| Adler, G | 1 |
| Dikopoulos, N | 1 |
| Fujisaku, A | 1 |
| Konno, T | 1 |
| Shibaki, H | 1 |
| Shinzato, Y | 1 |
| Ozawa, T | 1 |
| Sherlock, S | 6 |
| Revillard, JP | 1 |
| Auer, IO | 1 |
| Nouri-Aria, KT | 1 |
| Hegarty, JE | 1 |
| Alexander, GJ | 3 |
| Eddleston, AL | 2 |
| Williams, R | 4 |
| Idrisova, RS | 1 |
| Tsoĭ, IG | 1 |
| Hütteroth, TH | 1 |
| Poralla, T | 1 |
| Meyer zum Büschenfelde, KH | 1 |
| Suga, M | 1 |
| Sakamoto, S | 1 |
| Farber, NA | 2 |
| Ketiladze, ES | 1 |
| Kamilov, FKh | 1 |
| Ambrozaĭtis, AK | 1 |
| Braginskiĭ, DM | 1 |
| Vasil'ev, VS | 1 |
| Komar, VI | 1 |
| Kareva, LIa | 1 |
| Vasil'eva, AN | 1 |
| Andreĭchin, MA | 1 |
| Vasil'eva, NA | 1 |
| Donich, NS | 1 |
| Pár, A | 1 |
| Paál, M | 1 |
| Kádas, I | 1 |
| Kerekes, E | 1 |
| Jávor, T | 1 |
| Thomas, HC | 4 |
| Brown, D | 1 |
| Labrooy, J | 1 |
| Epstein, O | 1 |
| Liaw, YF | 4 |
| Chu, CM | 4 |
| Huang, MJ | 1 |
| Lin, DY | 1 |
| Chang-Chien, CS | 1 |
| Lam, KC | 1 |
| Lai, CL | 1 |
| Trepo, C | 3 |
| Wu, PC | 1 |
| Schalm, SW | 2 |
| Aleksandrovskaia, RA | 2 |
| Matveev, VA | 1 |
| Rozdin, AM | 1 |
| Gaevskaia, LV | 1 |
| Weller, IV | 1 |
| Bassendine, MF | 1 |
| Murray, AK | 1 |
| Craxi, A | 1 |
| Hoofnagle, JH | 2 |
| Seeff, LB | 2 |
| Makhmudov, OS | 1 |
| Mukhamedov, DB | 1 |
| Mansurov, KhKh | 3 |
| Eĭtsen, EF | 1 |
| Mirodzhov, GK | 2 |
| Tareev, EM | 1 |
| Aprosina, ZG | 1 |
| Kirk, AP | 1 |
| Dooley, JS | 1 |
| Hunt, RH | 1 |
| Redeker, AG | 1 |
| Gubskiĭ, LV | 1 |
| Malyshev, NA | 1 |
| Kirzhner, LS | 1 |
| Lemmens, HP | 2 |
| Langrehr, JM | 2 |
| Blumhardt, G | 1 |
| Lohmann, R | 2 |
| Knoop, M | 2 |
| Verschl, J | 1 |
| Schattenfroh, N | 1 |
| Neuhaus, R | 1 |
| Hopf, U | 2 |
| Bechstein, WO | 1 |
| Keck, H | 1 |
| Neumann, U | 1 |
| Müller, AR | 1 |
| Platz, KP | 1 |
| Kling, N | 1 |
| Giacchino, R | 3 |
| Main, J | 3 |
| Timitilli, A | 3 |
| Giambartolomei, G | 2 |
| Facco, F | 3 |
| Cirillo, C | 3 |
| Jacyna, MR | 1 |
| Brook, MG | 3 |
| Callea, F | 1 |
| Kariayannis, P | 1 |
| Schofield, K | 1 |
| Morris, D | 1 |
| Klapper, P | 1 |
| Bhaskaran, S | 1 |
| Mani, MK | 1 |
| Prakash, KC | 1 |
| Glück, T | 1 |
| Weber, P | 1 |
| Wiedmann, KH | 1 |
| Lin, SM | 3 |
| Chen, TJ | 2 |
| Chien, RN | 1 |
| Sheen, IS | 3 |
| Guillevin, L | 2 |
| Lhote, F | 1 |
| Leon, A | 1 |
| Fauvelle, F | 1 |
| Vivitski, L | 1 |
| Fedorchenko, SV | 1 |
| Vovk, AD | 1 |
| Rybalko, SL | 1 |
| Iino, S | 1 |
| Hino, K | 2 |
| Yasuda, K | 1 |
| Hamada, T | 1 |
| Kumashiro, R | 1 |
| Koga, Y | 1 |
| Hino, T | 1 |
| Furudera, S | 1 |
| Sakisaka, S | 1 |
| Sata, M | 1 |
| Tanikawa, K | 1 |
| Taguchi, J | 1 |
| Kage, M | 1 |
| Hayasaka, A | 2 |
| Kohen, H | 2 |
| Yoshikawa, N | 1 |
| Iida, S | 2 |
| Ohto, M | 3 |
| Perez, V | 1 |
| Findor, J | 1 |
| Tanno, H | 2 |
| Sordá, J | 1 |
| Yap, I | 1 |
| Chan, G | 1 |
| Karayiannis, P | 1 |
| Crossey, M | 1 |
| Lau, JY | 2 |
| Bird, GL | 2 |
| How, W | 1 |
| Ng, WC | 1 |
| Tan, MF | 1 |
| Seet, BL | 1 |
| Guan, R | 1 |
| Murakami, C | 1 |
| Okazaki, M | 1 |
| Fujii, K | 1 |
| Okuda, M | 1 |
| Hanada, H | 1 |
| Yamasaki, T | 1 |
| Okita, K | 1 |
| Kliem, V | 1 |
| van den Hoff, U | 1 |
| Brunkhorst, R | 1 |
| Tillmann, HL | 1 |
| Flik, J | 1 |
| Manns, MP | 1 |
| Pichlmayr, R | 1 |
| Koch, KM | 1 |
| Frei, U | 1 |
| Krogsgaard, K | 1 |
| Marcellin, P | 1 |
| Berthelot, P | 1 |
| Sanchez-Tapias, JM | 1 |
| Bassendine, M | 1 |
| Tran, A | 1 |
| Ouzan, D | 1 |
| Ring-Larsen, H | 1 |
| Lindberg, J | 1 |
| Enriquez, J | 1 |
| Benhamou, JP | 1 |
| Bindslev, N | 1 |
| Lengyel, G | 1 |
| Inadomi, T | 1 |
| Saito, T | 1 |
| Kaneko, M | 1 |
| Hashimoto, T | 2 |
| Suzuki, H | 3 |
| Nakanishi, K | 1 |
| Ishikawa, M | 1 |
| Nakauchi, M | 1 |
| Sakurai, A | 1 |
| Doi, K | 1 |
| Taniguchi, Y | 1 |
| Endo, M | 1 |
| Ohi, H | 1 |
| Fujita, T | 1 |
| Ohsawa, I | 1 |
| Kanmatsuse, K | 1 |
| Yamaguchi, Y | 1 |
| Higuchi, D | 1 |
| Sekiyama, K | 1 |
| Yoshiba, M | 1 |
| Inoue, K | 2 |
| Fujita, R | 1 |
| ter Borg, F | 1 |
| Smorenburg, S | 1 |
| de Man, RA | 2 |
| Rietbroek, RC | 1 |
| Chamuleau, RA | 1 |
| Jones, EA | 2 |
| Hsieh, H | 1 |
| Chien, YS | 1 |
| Hsu, KT | 1 |
| Chung, HM | 1 |
| Takagi, S | 1 |
| Nishikawa, M | 1 |
| Suzuki, M | 1 |
| Miyashita, A | 1 |
| Hashizume, T | 1 |
| Kakemizu, N | 1 |
| Ikeda, H | 1 |
| Suzuki, S | 1 |
| Okubo, T | 1 |
| Butani, L | 1 |
| Polinsky, MS | 1 |
| Taskapan, H | 1 |
| Oymak, O | 1 |
| Dogukan, A | 1 |
| Ozbakir, O | 1 |
| Utas, C | 1 |
| Minota, S | 1 |
| Erhardt, A | 1 |
| Sagir, A | 1 |
| Neuen-Jacob, E | 1 |
| Häussinger, D | 1 |
| Lau, CF | 1 |
| Hui, PK | 1 |
| Chan, WM | 1 |
| Fung, TT | 1 |
| Tung, YM | 1 |
| Loo, CK | 1 |
| Yip, WC | 1 |
| Lam, KM | 1 |
| Galbraith, RM | 1 |
| Zuckerman, AJ | 1 |
| Schmidt, P | 2 |
| Zazgornik, J | 2 |
| Pesendorfer, FX | 1 |
| Kopsa, H | 1 |
| Pils, P | 2 |
| Wewalka, F | 1 |
| Deutsch, E | 1 |
| Matveev, AA | 1 |
| Lapushiniskiĭ, DP | 1 |
| Cherednichenko, TV | 1 |
| Schimmelpfennig, W | 1 |
| Sasaki, H | 1 |
| Ichida, F | 1 |
| Sato, E | 1 |
| Onuki, K | 1 |
| Gasbarrini, G | 1 |
| Bernardi, M | 1 |
| Corazza, GR | 1 |
| Battista, P | 1 |
| Di Tano, G | 1 |
| Di Primio, R | 1 |
| Martinelli, G | 1 |
| Gábor, T | 1 |
| Erzsébet, M | 1 |
| Kornél, B | 1 |
| György, S | 1 |
| Ilona, L | 1 |
| Bubliĭ, VP | 1 |
| Hopsa, H | 1 |
| Mayr, WR | 1 |
| Kotzaurek, R | 1 |
| Golob, E | 1 |
| Friedrich, F | 1 |
| Piza, F | 1 |
| Wagner, O | 1 |
| Kux, M | 1 |
| Kühn, HA | 1 |
| Lesnicar, J | 1 |
| Ferluga, D | 1 |
| Lesnicar, G | 1 |
| Zhigalin, IM | 1 |
| Boĭkov, VP | 1 |
| Beckenbach, H | 1 |
| Hofmann, W | 1 |
| Rapp, W | 1 |
| Kommerell, B | 1 |
| Thamer, G | 1 |
| Graw, H | 1 |
| Bosch, A | 1 |
| Gmelin, K | 1 |
| Wilson, S | 1 |
| Logan, LM | 1 |
| Il'inskiĭ, IuA | 1 |
| Pak, SG | 1 |
| Brodov, LE | 1 |
| Luchshev, VI | 1 |
| Zabarskiĭ, LT | 1 |
| Niederau, C | 1 |
| Heintges, T | 1 |
| Niederau, M | 1 |
| Stremmel, W | 1 |
| Strohmeyer, G | 2 |
| Soh, LT | 1 |
| Ang, PT | 1 |
| Sng, I | 1 |
| Chua, EJ | 1 |
| Ong, YW | 1 |
| Sharma, RK | 1 |
| Elhence, R | 1 |
| Kher, V | 1 |
| Naik, SR | 1 |
| Bhandari, M | 1 |
| Takano, S | 1 |
| Omata, M | 5 |
| Imazeki, F | 3 |
| Nakagawa, H | 1 |
| Tanaka, S | 1 |
| Takashima, T | 1 |
| Shizumi, Y | 1 |
| Nishigaki, H | 1 |
| Horiike, S | 1 |
| Taniwaki, M | 1 |
| Misawa, S | 1 |
| Kashima, K | 1 |
| Hironaka, T | 1 |
| Gimson, AE | 1 |
| Berk, L | 1 |
| Stijnen, T | 1 |
| Ohtsu, T | 1 |
| Sai, T | 1 |
| Oka, M | 1 |
| Sugai, Y | 1 |
| Tobinai, K | 1 |
| Ilamanov, M | 1 |
| Naumova, VI | 1 |
| Podymova, SD | 1 |
| Fei, GZ | 1 |
| Sylvan, SP | 1 |
| Hellström, UB | 1 |
| Yao, GB | 1 |
| Sautereau, D | 1 |
| Cessot, F | 1 |
| Gainant, A | 1 |
| Andrieux, V | 1 |
| Letard, JC | 1 |
| Devalois, B | 1 |
| Catanzano, G | 1 |
| Claude, R | 1 |
| Pillegand, B | 1 |
| Brissot, P | 1 |
| Jacquelinet, C | 1 |
| Jouanolle, H | 1 |
| David, V | 1 |
| Guyader, D | 1 |
| Guéguen, M | 1 |
| Blayau, M | 1 |
| Lescoat, G | 1 |
| Messner, M | 1 |
| Deugnier, Y | 1 |
| Lee, SD | 1 |
| Wu, JC | 1 |
| Lin, HC | 1 |
| Tsai, YT | 1 |
| Lo, KJ | 1 |
| Egorov, VB | 1 |
| Gol'zand, IV | 1 |
| Itoh, S | 1 |
| Matsuo, S | 1 |
| Oda, T | 1 |
| Marutani, K | 1 |
| Sasaki, K | 1 |
| Uchiumi, K | 3 |
| Yamada, H | 1 |
| Shimizu, H | 1 |
| Taniguchi, O | 1 |
| Okumura, K | 1 |
| Yoo, JY | 1 |
| Kim, HY | 1 |
| Park, CK | 1 |
| Shim, KS | 1 |
| Chung, WK | 1 |
| Lai, MK | 1 |
| Huang, CC | 1 |
| Chu, SH | 1 |
| Chuang, CK | 1 |
| Fong, MT | 1 |
| Loy, A | 1 |
| Navone, C | 2 |
| Ciravegna, B | 1 |
| Pisani, N | 1 |
| Balikin, VF | 1 |
| Panova, LA | 1 |
| Sukharev, VM | 1 |
| Semenkova, EN | 1 |
| Lopatkina, TN | 1 |
| Fay, OH | 1 |
| Rojman, JA | 1 |
| Palazzi, J | 1 |
| Bessone, F | 1 |
| Barigione, G | 1 |
| Terragna, A | 1 |
| Onwubalili, JK | 1 |
| Hirai, N | 1 |
| Shimizu, M | 2 |
| Morioka, T | 1 |
| Hinoue, Y | 1 |
| Tanaka, N | 1 |
| Kobayashi, K | 1 |
| Hattori, N | 1 |
| Tokita, H | 1 |
| Takahashi, Y | 1 |
| Tanaka, H | 1 |
| Yasuda, M | 1 |
| Kojima, M | 2 |
| Adachi, N | 1 |
| Yoshida, H | 1 |
| Asfandiiarova, NS | 1 |
| Nikolaeva, OS | 1 |
| Mansurova, FKh | 1 |
| Rasunova, TKh | 1 |
| Ishiyama, T | 1 |
| Abe, S | 1 |
| Horie, S | 1 |
| Sugaya, N | 1 |
| Wakabayashi, Y | 1 |
| Hirose, S | 1 |
| Kumada, H | 1 |
| Ikeda, K | 1 |
| Yoshida, A | 1 |
| Seto, S | 1 |
| Tsukada, T | 1 |
| Mayumi, M | 1 |
| Ohlen, J | 1 |
| Selmair, H | 1 |
| Hirota, K | 2 |
| Sherker, AH | 1 |
| Okuda, K | 3 |
| Buti, M | 1 |
| Esteban, R | 1 |
| Esteban, JI | 1 |
| Gonzalez, A | 1 |
| Guardia, J | 1 |
| Mishanina, ZG | 1 |
| Pavlov, VL | 1 |
| Wiese, M | 1 |
| Storch, W | 1 |
| Künzel, R | 1 |
| Davis, GL | 1 |
| Pappas, SC | 1 |
| Hanson, RG | 1 |
| Peters, M | 1 |
| Avigan, MI | 1 |
| Waggoner, JG | 1 |
| Ito, Y | 2 |
| Mori, J | 2 |
| Liashenko, IuI | 1 |
| Kubenskiĭ, EN | 1 |
| Rychkov, VV | 1 |
| Martini, GA | 1 |
| Vatushin, NT | 1 |
| Tverskaia, ShN | 1 |
| Cho, ES | 1 |
| Connolly, E | 1 |
| Porro, RS | 1 |
| Nisevich, NI | 1 |
| Matkovics, A | 1 |
| Hollós, I | 1 |
| Darvas, G | 1 |
| Torisu, M | 1 |
| Yokoyama, T | 1 |
| Amemiya, H | 1 |
| Kohler, PF | 1 |
| Schroter, G | 1 |
| Martineau, G | 1 |
| Penn, I | 1 |
| Palmer, W | 1 |
| Halgrimson, CG | 1 |
| Putnam, CW | 1 |
| Starzl, TE | 1 |
| Ernst, S | 1 |
12 reviews available for prednisolone and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Dermatomyositis as an extrahepatic manifestation of hepatitis B virus-related hepatocellular carcinoma: A case report and literature review.
Topics: alpha-Fetoproteins; Antiviral Agents; Carcinoma, Hepatocellular; Catheter Ablation; Dermatomyositis; | 2018 |
[Polyarteritis nodosa (PAN)].
Topics: Adrenal Cortex Hormones; Cyclophosphamide; Drug Therapy, Combination; Hepatitis B; Humans; Immune Co | 2005 |
T cell subsets in autoimmune and HBV-induced chronic liver disease, HBs antigen carriers with normal histology and primary biliary cirrhosis: a review of the abnormalities and the effects of treatment.
Topics: Antibodies, Monoclonal; Autoimmune Diseases; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surfac | 1982 |
[Synthetic glucocorticoid therapy in liver diseases].
Topics: Autoimmune Diseases; Glucocorticoids; Hepatitis B; Hepatitis C; Humans; Liver Cirrhosis, Biliary; Li | 1994 |
[Polyarteritis nodosa and microscopic polyangiitis].
Topics: Antibodies, Antineutrophil Cytoplasmic; Central Nervous System Diseases; Diagnosis, Differential; He | 2000 |
[Current aspects of the therapy of chronic hepatitis (a review of the literature)].
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Adult; Azathioprine; BCG Vaccine; Child; Chronic Di | 1979 |
[Chronic hepatitis].
Topics: Azathioprine; Hepatitis; Hepatitis B; Humans; Liver Cirrhosis; Prednisolone; Prednisone; Prognosis | 1976 |
Acute erythroleukemia with t(3;5) accompanied by hepatocellular carcinoma.
Topics: Aclarubicin; Adolescent; Adult; Aged; Anemia, Refractory, with Excess of Blasts; Carcinoma, Hepatoce | 1991 |
Treatment of chronic viral hepatitis.
Topics: Acyclovir; Hepatitis B; Hepatitis C; Hepatitis D; Hepatitis, Chronic; Humans; Interferons; Prednisol | 1991 |
Therapy of chronic viral hepatitis.
Topics: Antiviral Agents; Chronic Disease; Clinical Protocols; Clinical Trials as Topic; Combined Modality T | 1991 |
[Problem of chronic hepatitis (classification, pathogenesis and treatment].
Topics: Autoimmune Diseases; Azathioprine; Chronic Disease; Hepatitis; Hepatitis B; Hepatitis B Antibodies; | 1991 |
Hepatitis B viral infection.
Topics: Acyclovir; Adult; Hepatitis B; Humans; Infant, Newborn; Interferon Type I; Interferon-gamma; Interle | 1988 |
27 trials available for prednisolone and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplas | 2003 |
Hepatitis-B virus-associated nephropathies in adults: a clinical study in Thailand.
Topics: Adult; Aged; Antiviral Agents; Biopsy; Female; Glomerulonephritis; Glucocorticoids; Hematuria; Hepat | 2006 |
Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study).
Topics: Benzopyrans; Catechin; Drug Therapy, Combination; Hepatitis B; Hepatitis, Chronic; Humans; Liver Fun | 1983 |
Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; Chronic Disease; Clinical Trial | 1981 |
Effects of prednisolone/azathioprine in chronic hepatitis B viral infection.
Topics: Azathioprine; Chronic Disease; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; | 1982 |
Dual-centre, double-blind, randomised trial of lymphoblastoid interferon alpha with or without steroid pretreatment in children with chronic hepatitis B.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Chronic Disease; DNA, Viral; Double-Blind Method; Drug | 1995 |
Beneficial effect of prednisolone withdrawal followed by human lymphoblastoid interferon on the treatment of chronic type B hepatitis in Asians: a randomized controlled trial.
Topics: Adult; Alanine Transaminase; DNA, Viral; Drug Therapy, Combination; Ethnicity; Hepatitis B; Hepatiti | 1994 |
Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients.
Topics: Adult; Aged; Cause of Death; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Live | 1993 |
The effect of interferon alpha and prednisolone on the serum concentrations of the aminoterminal domain of procollagen type III(PIIIP) and type IV (7-S collagen) in patients with chronic hepatitis B.
Topics: Adolescent; Adult; Aged; Chronic Disease; Collagen; Female; Follow-Up Studies; Hepatitis B; Humans; | 1993 |
A controlled trial of high dose interferon, alone and after prednisone withdrawal, in the treatment of chronic hepatitis B: long term follow up.
Topics: Alanine Transaminase; Chronic Disease; Drug Administration Schedule; Drug Therapy, Combination; Foll | 1993 |
Short report: prednisolone withdrawal followed by lymphoblastoid interferon in the therapy of adult patients with presumed childhood-acquired chronic hepatitis B virus infection.
Topics: Adolescent; Adult; Chronic Disease; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatit | 1993 |
Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial Group.
Topics: Adult; Antiviral Agents; Biopsy; Chronic Disease; DNA, Viral; Dose-Response Relationship, Drug; Doub | 1996 |
[Clinical effectiveness of prednisolone therapy in a controlled study and the procedural questions of using corticosteroids in serum hepatitis].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Clinical Trials as Topic; Drug Evaluation; Female; Hepat | 1978 |
Immunosuppressive therapy in chronic liver disease.
Topics: Azathioprine; Chronic Disease; Drug Therapy, Combination; Hepatitis; Hepatitis B; Hepatitis B Surfac | 1978 |
Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
Topics: Adolescent; Adult; Aged; Aspartate Aminotransferases; DNA, Viral; Drug Therapy, Combination; Female; | 1992 |
Short-term prednisolone followed by recombinant human alpha-interferon alone or combined with adenine-arabinoside in chronic hepatitis B. A prospective and randomized trial.
Topics: Adult; Chronic Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Humans; I | 1991 |
A randomised double-blind placebo-controlled trial of prednisolone therapy in HBeAg and HBV DNA positive Chinese patients with chronic active hepatitis B.
Topics: Adult; China; DNA, Viral; Double-Blind Method; Drug Administration Schedule; Female; Hematologic Tes | 1991 |
[Chronic active hepatitis B in children: effects of various methods of treatment].
Topics: Adjuvants, Immunologic; Child; Female; Hepatitis B; Hepatitis, Chronic; Humans; Immunologic Deficien | 1991 |
Renal transplantation in hepatitis B carriers: comparison of azathioprine- and cyclosporine-treated recipients.
Topics: Azathioprine; Carrier State; Cyclosporins; Female; Graft Survival; Hepatitis B; Humans; Kidney Disea | 1989 |
Steroids in chronic B-hepatitis. A randomized, double-blind, multinational trial on the effect of low-dose, long-term treatment on survival. A trial group of the European Association for the Study of the Liver.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Chronic Disease; Double-Blind Method; Female; Hep | 1986 |
Treatment of chronic type B hepatitis in Southeast Asia.
Topics: Asia, Southeastern; Clinical Trials as Topic; Female; Hepatitis B; Hepatitis, Chronic; Humans; Immun | 1988 |
HBeAg/anti-HBe seroconversion during and after protracted immunosuppressive treatment in type B chronic hepatitis.
Topics: Azathioprine; Clinical Trials as Topic; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; | 1988 |
Treatment of children with chronic hepatitis B with a combination of steroids and human lymphoblastoid interferon.
Topics: Adolescent; Alanine Transaminase; Child; Child, Preschool; Clinical Trials as Topic; Combined Modali | 1988 |
[Evaluation of therapeutic effectiveness of prednisolone in patients with chronic active hepatitis based on the morphometry of liver biopsy specimens].
Topics: Ascorbic Acid; Clinical Trials as Topic; Drug Therapy, Combination; Follow-Up Studies; Hepatitis B; | 1985 |
A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Alanine Transaminase; DNA-Directed DNA Polymerase; Double-Blind Method; Drug Administration S | 1986 |
Recombinant leukocyte a interferon treatment in patients with chronic hepatitis B virus infection. Pharmacokinetics, tolerance, and biologic effects.
Topics: Adult; Body Temperature; Chronic Disease; DNA-Directed DNA Polymerase; DNA, Viral; Female; Hepatitis | 1985 |
Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B. A controlled study.
Topics: Adult; Alanine Transaminase; Chronic Disease; DNA-Directed DNA Polymerase; Drug Administration Sched | 1985 |
129 other studies available for prednisolone and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Hepatitis B virus reactivation after effective sofosbuvir and ribavirin treatment in a patient with occult hepatitis B virus infection.
Topics: Aged; Anti-Inflammatory Agents; Antiviral Agents; Cryoglobulinemia; DNA, Viral; Female; Guanine; Hep | 2017 |
Factorial Analysis of Hepatitis B Virus Reactivation-Induced Hepatitis B Using JADER.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Antineoplastic | 2017 |
Rituximab administration in a patient with pemphigus vulgaris following reactivation of occult hepatitis B virus infection.
Topics: Adult; Antigens, CD20; Antiviral Agents; Drug Therapy, Combination; Glucocorticoids; Hepatitis B; He | 2017 |
Hepatitis B virus infection in an HBsAb-positive lymphoma patient who received chemotherapy: A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Doxorubicin; Fem | 2017 |
Early Combination Therapy with Corticosteroid and Nucleoside Analogue Induces Rapid Resolution of Inflammation in Acute Liver Failure due to Transient Hepatitis B Virus Infection.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Drug Therapy, Combination; Female; Glucocorticoids; G | 2018 |
Drug induced hypersensitivity syndrome by triple therapy of peginterferon alpha2b, ribavirin and telaprevir in patient with double positive for HBV and HCV.
Topics: Antiviral Agents; Biomarkers; Coinfection; DNA, Viral; Drug Hypersensitivity Syndrome; Drug Substitu | 2013 |
Deep-seated mycosis.
Topics: Aspergillosis; Aspergillus fumigatus; Hepatitis B; Humans; Immunocompromised Host; Invasive Pulmonar | 2014 |
[Case report of introducing MMF and steroids as an immunosuppressive therapy after living-donor liver transplantation for a patient with the diabetic nephropathy].
Topics: Cyclosporine; Diabetic Nephropathies; Female; Hepatitis B; Humans; Immunosuppressive Agents; Kidney | 2014 |
Coexistence of hepatoma with mantle cell lymphoma in a hepatitis B carrier.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carcinoma, Hepatocellular | 2015 |
Efficacy and Safety of a Steroid-Free Immunosuppressive Regimen after Liver Transplantation for Hepatocellular Carcinoma.
Topics: Antibodies, Monoclonal; Basiliximab; Carcinoma, Hepatocellular; Drug Administration Schedule; Drug T | 2016 |
[Hepatitis B virus reactivation during chlorambucil and prednisolone treatment in an HBsAg-negative and anti-HBs-positive patient with B-cell chronic lymphocytic leukemia].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; Hepatitis B; Hepatitis B | 2008 |
Risk of hepatitis B virus reactivation in patients who are hepatitis B surface antigen negative/antibody to hepatitis B core antigen positive and the role of routine antiviral prophylaxis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2009 |
[A case of drug-induced liver injury caused by entecavir for treatment of hepatitis B virus reactivation during RCHOP in a patient with non-Hodgkin lymphoma].
Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineo | 2009 |
[Hepatitis B virus reactivation after cessation of prophylactic lamivudine therapy in B-cell lymphoma patients treated with rituximab combined CHOP therapy].
Topics: Adult; Aged; Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antine | 2009 |
Telbivudine use in a patient affected by occult hepatitis B virus and B-cell non-Hodgkin lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2010 |
A probable case of transfusion-transmitted hepatitis B virus infection in an immunosuppressed recipient caused by an occult HBV-infected donor with negative ID-NAT.
Topics: Acute Disease; Adult; Azathioprine; Blood Donors; Carrier State; Crohn Disease; DNA, Viral; False Ne | 2010 |
Risk of hepatitis B virus reactivation in patients with asthma or chronic obstructive pulmonary disease treated with corticosteroids.
Topics: Adult; Aged; Anti-Asthmatic Agents; Asthma; Female; Glucocorticoids; Hepatitis B; Hepatitis B Surfac | 2010 |
Membranous nephropathy in an HIV-positive patient complicated with hepatitis B virus infection.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Deoxycytidine; Emtricitabine | 2011 |
Prospective evaluation of seropositive occult hepatitis B viral infection in lymphoma patients receiving chemotherapy.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherap | 2011 |
Warm autoimmune haemolytic anaemia and autoimmune hepatitis in an asymptomatic carrier of hepatitis B virus.
Topics: Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents; Blood Transfusion; Carrier State; Child; Co | 2011 |
Does genotype predict response to treatment in children infected with hepatitis B perinatally?
Topics: Adenine; Adolescent; Anti-Inflammatory Agents; Antiviral Agents; Child; Child, Preschool; Clinical T | 2012 |
Epidermodysplasia verruciformis associated with plasmablastic lymphoma and hepatitis B virus infection.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Cyclophosphamide; Doxorubicin; E | 2012 |
SERUM HEPATITIS PRESENTING AS SUDDEN LOSS OF CONSCIOUSNESS.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; Clinical Enzyme Tests; Diagnosis, Diff | 1965 |
Acute pancreatitis and exacerbation of hepatitis B following reduced dose of prednisolone.
Topics: Acute Disease; Hepatitis B; Humans; Immunosuppressive Agents; Male; Middle Aged; Pancreas; Pancreati | 2003 |
Hepatitis B-assocciated adult-onset Still's disease presenting with neutrophilic urticaria.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Diagnosis, Differential; F | 2003 |
Hepatic failure due to fibrosing cholestatic hepatitis in a patient with pre-surface mutant hepatitis B virus and mixed connective tissue disease treated with prednisolone and chloroquine.
Topics: Adult; Chloroquine; Cholestasis; Fatal Outcome; Female; Hepatitis B; Hepatitis B Surface Antigens; H | 2004 |
Hepatitis B prophylaxis in patients undergoing chemotherapy for lymphoma: a decision analysis model.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cost-Benefit Analysis; Cyclophosph | 2007 |
[Hepatitis B associated polyarteriitis nodosa with cerebral vasculitis].
Topics: Anti-Inflammatory Agents; Antiviral Agents; Diagnosis, Differential; Hepatitis B; Hepatitis B Surfac | 2007 |
[A 40-year-old female patient with seronegative autoimmune hepatitis following a newly acquired hepatitis B infection].
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Autoimmunity; Biopsy; Female; Glucocorticoids; Hepat | 2008 |
[Case of periarteritis nodosa noted during the onset of primary hepatitis-B virus infection and successfully treated by pulse therapy].
Topics: Adult; Hepatitis B; Humans; Male; Polyarteritis Nodosa; Prednisolone | 1983 |
Treatment of chronic hepatitis.
Topics: Azathioprine; Chronic Disease; Hepatitis; Hepatitis B; Humans; Interferons; Levamisole; Prednisolone | 1980 |
Significance of beta 2-microglobulin in liver diseases.
Topics: beta 2-Microglobulin; Beta-Globulins; Chemical and Drug Induced Liver Injury; Chronic Disease; Hepat | 1980 |
[Therapy of chronic hepatitis (author's transl)].
Topics: Azathioprine; Chronic Disease; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antibodies; Hepat | 1980 |
Effect of corticosteroids on suppressor-cell activity in "autoimmune" and viral chronic active hepatitis.
Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Chronic Disease; Hepatitis; Hepatitis B; Hepatitis B S | 1982 |
[Indicators of cellular immunity in various types of treatment of children with chronic hepatitis B].
Topics: Adjuvants, Immunologic; Adolescent; Child; Chronic Disease; Hepatitis B; Hepatitis, Chronic; Humans; | 1984 |
Spontaneous cell-mediated (SCMC) and antibody-dependent cellular cytotoxicity (ADCC) in patients with acute and chronic active hepatitis.
Topics: Acute Disease; Antibody-Dependent Cell Cytotoxicity; Chronic Disease; Cytotoxicity, Immunologic; Hep | 1981 |
[Treatment of viral hepatitis. a) Immunopotentiator and steroids].
Topics: Adjuvants, Immunologic; Adult; Biological Products; Female; Hepatitis B; Hepatitis B Antibodies; Hep | 1984 |
[Levamisole in the therapy of viral hepatitis B].
Topics: Adolescent; Adult; Antibody Formation; Drug Therapy, Combination; Hepatitis B; Hepatitis B Surface A | 1983 |
[Tactics in using glucocorticosteroids in severe forms of viral hepatitis B].
Topics: Anti-Inflammatory Agents; Hepatitis B; Humans; Lipopolysaccharides; Plasma Substitutes; Povidone; Pr | 1983 |
[Clinical and biochemical evaluation of the pathogenetic therapy of viral hepatitis].
Topics: Adolescent; Adult; Aged; Combined Modality Therapy; Hepatitis A; Hepatitis B; Humans; Methylthiourac | 1983 |
Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis.
Topics: Adult; Alanine Transaminase; Antibody Formation; Azathioprine; Biopsy; Female; Hepatitis B; Hepatiti | 1983 |
[Should chronic active viral hepatitis be treated with drugs or not?].
Topics: Adjuvants, Immunologic; Antiviral Agents; Azathioprine; Carrier State; Hepatitis B; Hepatitis B Surf | 1981 |
[Side effects, complications and the late results of corticosteroid treatment in serum hepatitis].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Dose-Response Relationship, Drug; Follow-Up Studies; Hep | 1982 |
Natural history of chronic type B hepatitis.
Topics: Adult; Antigens, Viral; Carrier State; Chronic Disease; Follow-Up Studies; Hepatitis B; Humans; Male | 1982 |
Prednisolone in HBsAg-positive chronic active hepatitis.
Topics: Chronic Disease; Hepatitis B; Hepatitis B Surface Antigens; Humans; Prednisolone | 1981 |
[Immunological indices in hepatitis in children as dependent on treatment methods].
Topics: Adolescent; Child; Child, Preschool; Hepatitis A; Hepatitis B; Humans; Immunity; Infant; Prednisolon | 1981 |
[Glucocorticoids in therapy of HBs-positive viral hepatitis].
Topics: Adolescent; Hepatitis B; Hepatitis B Surface Antigens; Humans; Levamisole; Male; Prednisolone; Time | 1981 |
[General aspects of management and immunosuppressive therapy of chronic active hepatitis].
Topics: Azathioprine; Chronic Disease; Drug Therapy, Combination; Hepatitis B; Humans; Immunosuppressive Age | 1980 |
Peptic ulceration in patients with chronic liver disease.
Topics: Adult; Aged; Chronic Disease; Duodenal Ulcer; Female; Hepatitis B; Humans; Liver Cirrhosis; Liver Di | 1980 |
Treatment of chronic active hepatitis. Good news and bad news.
Topics: Female; Hepatitis; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis, Viral, Human; Humans; Male; | 1981 |
[Search for and perspectives of new methods of treatment of severe forms of hepatitis B].
Topics: Adolescent; Adult; Aged; Brain Edema; Diuretics; Hepatic Encephalopathy; Hepatitis B; Humans; Hyperb | 1980 |
Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis.
Topics: Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Cyclosporine; Drug Administration Schedu | 1994 |
Liver transplantation in hepatitis B surface antigen positive patients with postoperative long-term immunoprophylaxis.
Topics: Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Cyclosporine; DNA, Viral; Female; | 1995 |
Hepatitis after withdrawal of chemotherapy in a patient with chronic hepatitis B.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Eto | 1993 |
A study of hepatitis B surface antigen positive patients on haemodialysis and following transplantation.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Aspartate Aminotransferases; Azathioprine; Child; Femal | 1994 |
[Hepatitis-B-associated vasculitis. Clinical course with glucocorticoid and alpha-interferon therapy].
Topics: Adult; Female; Hepatitis B; Hepatitis, Chronic; Humans; Interferon-alpha; Prednisolone; Vasculitis | 1994 |
[The combined treatment with prednisolone and recombinant alpha 2-interferon of patients with chronic hepatitis B: the factors influencing the immune response].
Topics: Adult; Biomarkers; Chronic Disease; DNA, Viral; Drug Evaluation; Drug Therapy, Combination; Female; | 1994 |
Fatal acute hepatitis B virus infection while receiving immunosuppressants after renal transplantation.
Topics: Acute Disease; Cyclosporine; Fatal Outcome; Hepatitis B; Humans; Immunocompromised Host; Kidney Tran | 1993 |
Effects of immunosuppressive therapy on hepatic expression of hepatitis B viral genome and gene products.
Topics: Adult; Aged; Azathioprine; Biopsy; DNA, Viral; Gene Expression; Genome, Viral; Hepatitis B; Hepatiti | 1993 |
Severe clinical rebound upon withdrawal of corticosteroid before interferon therapy: incidence and risk factors.
Topics: Adult; Antiviral Agents; Chronic Disease; Female; Glucocorticoids; Hepatitis B; Humans; Incidence; I | 1996 |
Viral nucleotide changes in asymptomatic hepatitis B carriers undergoing interferon treatment.
Topics: Adult; Anti-Inflammatory Agents; Base Sequence; Carrier State; DNA, Viral; Female; Hepatitis B; Hepa | 1996 |
Hepatitis B virus carrier status linked to autoimmune hepatitis.
Topics: Adult; Alanine Transaminase; Autoantibodies; Autoimmune Diseases; Azathioprine; Biomarkers; Carrier | 1996 |
The long-term course of hepatitis C after kidney transplantation.
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Child; Cyclosporine; Female; Graft Rejection; Hemosid | 1996 |
[Therapeutic principles after liver transplantation].
Topics: Azathioprine; Cyclosporine; Female; Hepatitis B; Hepatitis C; Hepatitis D; Humans; Immunosuppressive | 1996 |
Bullous pemphigoid in an HB virus carrier: interaction between corticosteroids and HB virus.
Topics: Carrier State; Female; Hepatitis B; Humans; Liver Failure; Middle Aged; Pemphigoid, Bullous; Prednis | 1997 |
Antibody to hepatitis B e positive hepatitis induced by withdrawal of steroid therapy for polymyositis: response to interferon-alpha and cyclosporin A.
Topics: Alanine Transaminase; Anti-Inflammatory Agents; Aspartate Aminotransferases; Cyclosporine; DNA, Vira | 1998 |
Appearance of nephrotic syndrome following interferon-alpha therapy in a patient with hepatitis B virus and hepatitis C virus coinfection.
Topics: Anti-Inflammatory Agents; Female; Glomerulonephritis, Membranous; Hepatitis B; Hepatitis C; Humans; | 1998 |
[A close association of prognosis with effect of interferon in HBV carriers developing acute severe exacervation].
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Carrier State; Cyclosporine; Drug | 1998 |
Recovery from life-threatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Female; Glucocorticoids; Hep | 1998 |
Conversion to Sandimmun Neoral in stable renal transplant recipients over 1 year: hepatitis, liver dysfunction, dosing intervals, and therapeutic ranges.
Topics: Administration, Oral; Adult; Alanine Transaminase; Aspartate Aminotransferases; Cyclosporine; Dose-R | 1998 |
[Fulminant hepatic failure related to immunosuppressive therapy in an asymptomatic HBsAg carrier with idiopathic interstitial pneumonia].
Topics: Aged; Anti-Inflammatory Agents; Carrier State; Cyclophosphamide; Fatal Outcome; Female; Hepatitis B; | 1998 |
Safety and efficacy of corticosteroids in childhood nephrotic syndrome with concomitant hepatitis B.
Topics: Administration, Oral; Anti-Inflammatory Agents; Child, Preschool; Hepatitis B; Hepatitis B virus; Hu | 1999 |
Transformation of hepatitis B virus-related membranous glomerulonephritis to crescentic form.
Topics: Adult; Cyclosporine; Glomerulonephritis; Glomerulonephritis, Membranous; Hepatitis B; Hepatitis B vi | 2000 |
Successful treatment of hepatitis B virus associated polyarteritis nodosa with a combination of prednisolone, alpha-interferon and lamivudine.
Topics: Antiviral Agents; Base Sequence; Biopsy; DNA Primers; DNA, Viral; Drug Therapy, Combination; Genome, | 2000 |
Hepatitis B associated fulminant polyarteritis nodosa: successful treatment with pulse cyclophosphamide, prednisolone and lamivudine following emergency surgery.
Topics: Adult; Anti-Inflammatory Agents; Cyclophosphamide; Gastrointestinal Hemorrhage; Hepatitis B; Hepatit | 2002 |
Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy.
Topics: Adult; Antineoplastic Agents; Chlorambucil; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Female; | 1975 |
Viral hepatitis and cirrhosis.
Topics: Acute Disease; Adrenal Cortex Hormones; Azathioprine; Carcinoma, Hepatocellular; Chronic Disease; Di | 1975 |
[Hepatitis b infection in renal transplant recipients (author's transl)].
Topics: Azathioprine; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Antigens; Humans; Kidney Tran | 1978 |
[Current hepatitis therapy].
Topics: Bed Rest; Hepatitis A; Hepatitis B; Humans; Immunization; Immunosuppression Therapy; Prednisolone | 1979 |
[Steroid treatment of chronic hepatitis and subacute hepatitis (author's transl)].
Topics: Adult; Chronic Disease; Female; Hepatitis B; Humans; Liver Function Tests; Male; Middle Aged; Predni | 1979 |
[Prospects of antilymphocyte globulin therapy of acute hepatitis].
Topics: Antilymphocyte Serum; Fever; Hepatic Encephalopathy; Hepatitis B; Hepatitis B Antigens; Humans; Lymp | 1977 |
[HBsAg positive viral hepatitis, associated with acute infectious mononucleosis simptoms, treated with prednisolone].
Topics: Adult; Hepatitis B; Humans; Infectious Mononucleosis; Male; Prednisolone | 1978 |
[Effectiveness of treatment of viral hepatitis with prednisolone and lysozyme].
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Hepatitis B; Humans; Middle Aged; Muramidase; Pr | 1978 |
[Rejection of a kidney graft after pregnancy and delivery].
Topics: Adult; Azathioprine; Female; Glomerulonephritis; Glucocorticoids; Graft Rejection; Heparin; Hepatiti | 1976 |
Diagnosis and treatment of chronic active hepatitis.
Topics: Adolescent; Adult; Azathioprine; Chemical and Drug Induced Liver Injury; Chronic Disease; Female; He | 1977 |
[Therapy of hepatitis B. Practical implications].
Topics: Azathioprine; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antigens; Humans; Immunization; Im | 1977 |
Sequeale of acute viral hepatitis type B.
Topics: Acute Disease; Chronic Disease; Clinical Enzyme Tests; Follow-Up Studies; Hepatitis B; Hepatitis B A | 1977 |
[Acute steroid-induced stomach ulcer complicated by profuse hemorrhage in a patient with serum hepatitis].
Topics: Hepatitis B; Humans; Male; Middle Aged; Peptic Ulcer Hemorrhage; Prednisolone; Stomach Ulcer | 1976 |
[Attempts at transmission of HBs-Ag positive viral hepatitis to rats and mini-pigs].
Topics: Animals; Cyclophosphamide; Hepatitis B; Hepatitis B Antigens; Humans; Immunosuppression Therapy; Liv | 1976 |
Hepatitis B core antigen in the immunosuppressed chimpanzee.
Topics: Animals; Antibody Formation; Cyclophosphamide; Guinea Pigs; Hepatitis B; Hepatitis B Antigens; Immun | 1975 |
[Treatment of serum hepatitis].
Topics: Hepatitis B; Humans; Male; Middle Aged; Prednisolone | 1975 |
[Perforation of anastomosis of the transverse colon at remote postoperative period during prednisolone treatment].
Topics: Aged; Colon; Colonic Diseases; Colonic Neoplasms; Female; Hepatitis B; Humans; Intestinal Perforatio | 1975 |
Fulminant hepatic failure in non-Hodgkin lymphoma patients treated with chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemical and Drug Induced Li | 1992 |
Liver disease in renal transplant recipients.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Granuloma; Hepatitis; Hepa | 1992 |
Effects of antiviral agents on chronic hepatitis B. Analysis using Cox proportional hazard model.
Topics: Antiviral Agents; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Stu | 1992 |
Treatment of HBV reactivation after withdrawal of immunosuppression.
Topics: Chemical and Drug Induced Liver Injury, Chronic; Hepatitis B; Hepatitis B virus; Hepatitis, Chronic; | 1991 |
Activation of hepatitis B virus infection by chemotherapy containing glucocorticoid in hepatitis B virus carriers with hematologic malignancies.
Topics: Adult; Aged; Antineoplastic Agents; Carrier State; Female; Hematologic Diseases; Hepatitis B; Humans | 1991 |
[Results of the treatment of glomerulonephritis in children with hepatitis B].
Topics: Adolescent; Age Factors; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Drug Resistance; D | 1991 |
IgM anti-preS2 monitoring during combined corticosteroid/interferon-alpha 2b therapy in chronic hepatitis B.
Topics: Adult; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Hepatitis B; Hepatitis B Antibo | 1991 |
[Cases of chronic hepatitis which showed clear changes of serum levels of 7S-collagen in response to steroid and interferon therapy].
Topics: Aged; Autoimmune Diseases; Chronic Disease; Collagen; Female; Hepatitis; Hepatitis B; Hepatitis, Chr | 1991 |
[Alithiasic cholecystitis and viral hepatitis B disclosing periarteritis nodosa].
Topics: Adult; Cholecystitis; Hepatitis B; Humans; Male; Polyarteritis Nodosa; Prednisolone | 1990 |
[Treatment of hepatitis B].
Topics: Catechin; Chronic Disease; Hepatitis B; Humans; Interferon Type I; Liver Function Tests; Prednisolon | 1990 |
Triiodothyronine level and triiodothyronine/thyroxine ratio in HBeAg-positive chronic hepatitis patients treated with prednisolone withdrawal.
Topics: Adult; Alanine Transaminase; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis, Chr | 1990 |
Combination of prednisolone withdrawal and antiviral agents (adenine arabinoside, interferon) in chronic hepatitis B. A long-term follow-up study.
Topics: Antiviral Agents; Drug Therapy, Combination; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; | 1986 |
Leu-1(CD5) B cell subpopulation in patients with various liver diseases--special reference to hepatitis B virus carrier and to changes caused by prednisolone therapy.
Topics: Adult; Aged; Antigens, Differentiation; B-Lymphocytes; Carrier State; CD5 Antigens; Female; Flow Cyt | 1988 |
Effect of short-term prednisolone therapy in patients with severe chronic type B hepatitis.
Topics: Adolescent; Adult; Biopsy; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surf | 1989 |
[Reactivation of virus replication during immunosuppressive therapy in children with chronic hepatitis B].
Topics: Azathioprine; Child; DNA Replication; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepat | 1989 |
[Cortisol level and immunosuppression in viral hepatitis B in children and the approach to its treatment with glucocorticoids].
Topics: Adolescent; Child; Child, Preschool; Hepatitis B; Humans; Hydrocortisone; Immune Tolerance; Immunogl | 1989 |
[Treatment of periarteritis nodosa with immunosuppressants].
Topics: Adolescent; Adult; Azathioprine; Carrier State; Drug Therapy, Combination; Female; Hepatitis B; Hepa | 1985 |
Treatment of hepatitis.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Hepatitis C; Hepatitis D; Hepatitis, Viral | 1988 |
Fulminant hepatic failure in nephrotic syndrome related to withdrawal of immunosuppressive therapy.
Topics: Adolescent; Hepatitis B; Humans; Immunosuppressive Agents; Male; Middle Aged; Nephrotic Syndrome; Pr | 1988 |
Activities of the interferon system in patients with HBsAg-positive chronic hepatitis B during short-term steroid withdrawal therapy.
Topics: 2',5'-Oligoadenylate Synthetase; Adult; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hep | 1988 |
[Back-ground factors which affect the outcome of steroid withdrawal therapy in patients with chronic type B hepatitis--statistical evaluation of the importance of the mode of HBV transmission].
Topics: Adolescent; Adult; Alanine Transaminase; Child; Female; Follow-Up Studies; Hepatitis B; Hepatitis B | 1987 |
[Immunocorrective therapy of patients with chronic active liver diseases of a viral nature].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Azathioprine; Female; Hepatitis B; Hepatitis, Chronic; Hu | 1987 |
[Acute hepatitis type B complicated by hemolytic anemia].
Topics: Acute Disease; Adult; Anemia, Hemolytic; Female; Hepatitis B; Humans; Prednisolone | 1987 |
Short-term prednisolone for inducing seroconversion from hepatitis B e antigen to antibody along with clinical improvement in patients with chronic active hepatitis type B.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; DNA-Directed DNA Polymerase; Female; Follo | 1987 |
[Chronic aggressive hepatitis B: effectiveness of the control of immunosuppressive therapy. Value of biopsy and laboratory chemical procedures].
Topics: Acetylglucosaminidase; Adolescent; Adult; Azathioprine; Biopsy; Drug Therapy, Combination; Female; H | 1986 |
Effects of adenine arabinoside and corticosteroid on replication of duck hepatitis B virus DNA in the liver.
Topics: Adrenal Cortex Hormones; Animals; Dexamethasone; DNA Replication; DNA, Viral; Ducks; Hepatitis B; He | 1986 |
Severe hepatic failure after ARA-A-prednisolone for chronic type B hepatitis.
Topics: Adult; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Hepatitis B; Humans; Male; | 1987 |
[Virus-associated chronic autoimmune aggressive hepatitis (HBsAg seronegative) with pronounced diarrhea].
Topics: Adolescent; Autoimmune Diseases; Azathioprine; Biopsy; Complement System Proteins; Diarrhea; Fluores | 1985 |
[Hyperbaric oxygenation in combined therapy of viral hepatitis].
Topics: Combined Modality Therapy; Hepatitis B; Humans; Hyperbaric Oxygenation; Prednisolone; Time Factors | 1985 |
[Treatment and prevention of acute viral hepatitis (A and B)].
Topics: Acute Disease; Antibody Formation; Bedding and Linens; Cholestasis; Female; gamma-Globulins; Hepatit | 1973 |
[Perforation of an anastomosis of the large intestine after prednisolone treatment].
Topics: Hepatitis B; Humans; Intestinal Perforation; Intestine, Large; Male; Middle Aged; Prednisolone | 1974 |
What shall we do with the HBAg carrier?
Topics: Aspartate Aminotransferases; Azathioprine; Biopsy; Carrier State; Chronic Disease; Hepatitis B; Hepa | 1974 |
Primary reticulum cell sarcoma of the brain in a renal transplantation recipient.
Topics: Abscess; Adult; Azathioprine; Brain Neoplasms; Chronic Disease; Epididymitis; Frontal Lobe; Glomerul | 1974 |
[Viral hepatitis in children].
Topics: Adrenal Glands; Child, Preschool; Diagnosis, Differential; Hepatitis A; Hepatitis B; Hepatitis B Ant | 1973 |
[Experience with corticosteroid therapy of acute B type viral hepatitis].
Topics: Hepatitis A; Hepatitis B; Hepatitis B Antigens; Humans; Prednisolone | 1974 |
Immunosuppression, liver injury, and hepatitis in renal, hepatic, and cardiac homograft recipients: with particular reference to the Australia antigen.
Topics: Adult; Antibodies, Anti-Idiotypic; Aspartate Aminotransferases; Azathioprine; Bilirubin; Blood Prote | 1971 |
[Chronic hepatitis after transfusion hepatitis. Treatment of chronic active liver diseases after transfusion hepatitis with imurel].
Topics: Adolescent; Adult; Azathioprine; Chronic Disease; Hepatitis; Hepatitis A; Hepatitis B; Humans; Male; | 1971 |